These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37893220)

  • 1. Immunological Phenotyping of Mice with a Point Mutation in
    Yabas M; Hoyne GF
    Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant mice.
    Mettus RV; Rane SG
    Oncogene; 2003 Nov; 22(52):8413-21. PubMed ID: 14627982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdk4 is indispensable for postnatal proliferation of the anterior pituitary.
    Jirawatnotai S; Aziyu A; Osmundson EC; Moons DS; Zou X; Kineman RD; Kiyokawa H
    J Biol Chem; 2004 Dec; 279(49):51100-6. PubMed ID: 15456744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4.
    Chan FK; Zhang J; Cheng L; Shapiro DN; Winoto A
    Mol Cell Biol; 1995 May; 15(5):2682-8. PubMed ID: 7739548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point.
    Bisteau X; Paternot S; Colleoni B; Ecker K; Coulonval K; De Groote P; Declercq W; Hengst L; Roger PP
    PLoS Genet; 2013 May; 9(5):e1003546. PubMed ID: 23737759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors.
    Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC
    J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic evidence for functional dependency of p18Ink4c on Cdk4.
    Pei XH; Bai F; Tsutsui T; Kiyokawa H; Xiong Y
    Mol Cell Biol; 2004 Aug; 24(15):6653-64. PubMed ID: 15254233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours.
    Vax VV; Bibi R; Diaz-Cano S; Gueorguiev M; Kola B; Borboli N; Bressac-de Paillerets B; Walker GJ; Dedov II; Grossman AB; Korbonits M
    J Endocrinol; 2003 Aug; 178(2):301-10. PubMed ID: 12904177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of the D-type cyclin-dependent kinases Cdk4 and Cdk6, using a series of monoclonal antibodies.
    Lukas C; Jensen SK; Bartkova J; Lukas J; Bartek J
    Hybridoma; 1999 Jun; 18(3):225-34. PubMed ID: 10475236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression.
    Tam SW; Theodoras AM; Shay JW; Draetta GF; Pagano M
    Oncogene; 1994 Sep; 9(9):2663-74. PubMed ID: 8058330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6.
    Malumbres M; Sotillo R; Santamaría D; Galán J; Cerezo A; Ortega S; Dubus P; Barbacid M
    Cell; 2004 Aug; 118(4):493-504. PubMed ID: 15315761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
    Parry D; Mahony D; Wills K; Lees E
    Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGA2 cooperates with either p27
    Fedele M; Paciello O; De Biase D; Monaco M; Chiappetta G; Vitiello M; Barbieri A; Rea D; Luciano A; Papparella S; Arra C; Fusco A
    Cell Cycle; 2018; 17(5):580-588. PubMed ID: 29157111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.
    Bockstaele L; Bisteau X; Paternot S; Roger PP
    Mol Cell Biol; 2009 Aug; 29(15):4188-200. PubMed ID: 19487459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Driving the cell cycle to cancer.
    Malumbres M; Hunt SL; Sotillo R; Martín J; Odajima J; Martín A; Dubus P; Ortega S; Barbacid M
    Adv Exp Med Biol; 2003; 532():1-11. PubMed ID: 12908544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation.
    Franklin DS; Xiong Y
    Mol Biol Cell; 1996 Oct; 7(10):1587-99. PubMed ID: 8898364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
    Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2.
    Gillam MP; Nimbalkar D; Sun L; Christov K; Ray D; Kaldis P; Liu X; Kiyokawa H
    Oncogene; 2015 Feb; 34(7):932-8. PubMed ID: 24531709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity.
    Tsutsui T; Hesabi B; Moons DS; Pandolfi PP; Hansel KS; Koff A; Kiyokawa H
    Mol Cell Biol; 1999 Oct; 19(10):7011-9. PubMed ID: 10490638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.